Semler Scientific SMLR

NAS: SMLR | ISIN: US81684M1045   19:52
23,41 USD (+1,74%)
(+1,74%)   19:52

7 mei 2024 · Semler Scientific® Reports First Quarter 2024 Financial Results · Persbericht

23 april 2024 · Semler Scientific to Report First Quarter Financial Results and Host Conference Call on May 7, 2024 · Persbericht

5 maart 2024 · Semler Scientific Reports Fourth Quarter and Full Year 2023 Financial Results · Persbericht

21 februari 2024 · Semler Scientific to Report Fourth Quarter and Year End 2023 Financial Results and Host Conference Call on March 5, 2024 · Persbericht

9 november 2023 · Semler Scientific Reports Third Quarter and Year-to-Date 2023 Financial Results · Persbericht

26 oktober 2023 · Semler Scientific to Report Third Quarter and First Nine Months of 2023 Financial Results and Host Conference Call on November 9, 2023 · Persbericht

31 augustus 2023 · Semler Scientific to Present at Upcoming Investor Conference · Persbericht

10 augustus 2023 · Semler Scientific Reports Second Quarter and First Half of 2023 Financial Results · Persbericht

28 juli 2023 · Semler to Report Second Quarter 2023 Financial Results and Host Conference Call on August 10, 2023 · Persbericht

11 juli 2023 · Semler Scientific Announces Appointment of Chief Financial Officer, Record Quarterly Revenues and Strategic Streamlining · Persbericht

23 juni 2023 · Semler Scientific to Join the Russell 2000® and 3000® Indexes · Persbericht

10 mei 2023 · Semler Scientific Reports First Quarter 2023 Financial Results · Persbericht

1 mei 2023 · Semler to Report First Quarter 2023 Financial Results and Host Conference Call on May 10, 2023 · Persbericht

28 april 2023 · Semler Scientific Names Doug Murphy-Chutorian, M.D. as Interim CEO · Persbericht

19 april 2023 · Semler Scientific Announces Appointment of Eric Semler and William Chang as Directors · Persbericht

5 april 2023 · Semler Scientific to Participate in the 22nd Annual Needham Virtual Healthcare Conference · Persbericht

3 april 2023 · Semler Scientific Comments on CMS Risk Adjustment Changes in the 2024 Medicare Advantage and Part D Final Rate Announcement · Persbericht

21 maart 2023 · Semler Scientific Reports Fourth Quarter and Full Year 2022 Financial Results · Persbericht

21 maart 2023 · Semler Scientific Names Wayne T. Pan, M.D., Ph.D., M.B.A. as New CEO Effective April 3, 2023 · Persbericht

1 maart 2023 · Semler Announces Clinical Study Published Using QuantaFlo® as an Aid for Diagnosis of Heart Dysfunction in the Primary Care Setting · Persbericht

Mijn selecties